Skip to main content

Featured

Interparfums FY 2022: record earnings as operating profit soars 33 percent

THE WHAT? Interparfums has reported its results for the 2022 fiscal year. The fragrance giant recorded record earnings for the full year with net income up 40 percent on 2021’s figures and sales rising 26 percent to €706.6 million. THE DETAILS The company noted that it had extended its partnership with Montblanc until December 31, 2030 and, subject to the General Meeting’s ratification, hit its goal of achieving gender parity on its board. THE WHY? Philippe Benacin, Chairman and CEO, commented, “Against the backdrop of a turbulent economic and geopolitical environment, our sales and earnings continued to grow in 2022. In 2023, although many uncertainties still exist, this positive momentum should continue with sales expected to reach €750 million, driven by the continuing appeal of our brands for consumers in a global perfume market that remains buoyant.” The post Interparfums FY 2022: record earnings as operating profit soars 33 percen...
1 comment
Read more
Labels

[17 min watch] Common benign lesions | Part 1

[17 min watch] Common benign lesions | Part 1

[17 min watch] Common benign lesions | Part 1

In this first video in a two-part series, Professor Giuseppe Argenziano looks at common benign lesions encountered in primary care and outlines their clinical and dermoscopic clues, with real patient cases. For further information on this topic, you may be interested to learn more about the HealthCert Professional Diploma program in Dermoscopy. Benign skin lesions […]

The post [17 min watch] Common benign lesions | Part 1 appeared first on Skin Cancer Blog.

* This article was originally published here



* This article was originally published here
Labels:

Comments

Post a Comment

Popular Posts